Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
31001
31002
31003
31004
31005
31006
31007
31008
31009
31010
31011
31012
31013
31014
31015
31016
31017
31018
31019
31020
31021
31022
31023
31024
31025
31026
31027
31028
31029
31030
31031
31032
31033
31034
31035
31036
31037
31038
31039
31040
31041
31042
31043
31044
31045
31046
31047
31048
31049
31050
31051
31052
31053
31054
31055
31056
31057
31058
31059
31060
31061
31062
31063
31064
31065
31066
31067
31068
31069
31070
31071
31072
31073
31074
31075
31076
31077
31078
31079
31080
31081
31082
31083
31084
31085
31086
31087
31088
31089
31090
31091
31092
31093
31094
31095
31096
31097
31098
31099
31100
31101
31102
31103
31104
31105
31106
31107
31108
31109
31110
31111
31112
31113
31114
31115
31116
31117
31118
31119
31120
31121
31122
31123
31124
31125
31126
31127
31128
31129
31130
31131
31132
31133
31134
31135
31136
31137
31138
31139
31140
31141
31142
31143
31144
31145
31146
31147
31148
31149
31150
31151
31152
31153
31154
31155
31156
31157
31158
31159
31160
31161
31162
31163
31164
31165
31166
31167
31168
31169
31170
31171
31172
31173
31174
31175
31176
31177
31178
31179
31180
31181
31182
31183
31184
31185
31186
31187
31188
31189
31190
31191
31192
31193
31194
31195
31196
31197
31198
31199
31200
| UnnamedSample_HQ_transcript/7682|m.3083 | UnnamedSample_HQ_transcript/7682 | Identity 0.882 too low. | 548302462ac25e9be00cbcebfd1da948 | 178 | Pfam | PF01534 | Frizzled/Smoothened family membrane region | 1 | 91 | 1.4E-29 | T | 22-09-2020 | IPR000539 | Frizzled/Smoothened, transmembrane domain |
| UnnamedSample_HQ_transcript/75004|m.18843 | UnnamedSample_HQ_transcript/75004 | Unmapped. | 1e06c2e19253c854f1d17ec2fcb11fc5 | 138 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 2 | 122 | 1.5E-16 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/5975|m.2534 | UnnamedSample_HQ_transcript/5975 | Unmapped. | 614eb404c33e0b24814f585cb357731b | 1324 | Pfam | PF13086 | AAA domain | 539 | 609 | 6.2E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/5975|m.2534 | UnnamedSample_HQ_transcript/5975 | Unmapped. | 614eb404c33e0b24814f585cb357731b | 1324 | Pfam | PF13087 | AAA domain | 722 | 893 | 1.1E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/20210|m.6926 | UnnamedSample_HQ_transcript/20210 | Coverage 0.337 too low. | ca40edd772f23e126cb562101e22ed00 | 507 | Pfam | PF00630 | Filamin/ABP280 repeat | 416 | 504 | 1.1E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/20210|m.6926 | UnnamedSample_HQ_transcript/20210 | Coverage 0.337 too low. | ca40edd772f23e126cb562101e22ed00 | 507 | Pfam | PF00630 | Filamin/ABP280 repeat | 101 | 186 | 2.0E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/20210|m.6926 | UnnamedSample_HQ_transcript/20210 | Coverage 0.337 too low. | ca40edd772f23e126cb562101e22ed00 | 507 | Pfam | PF00630 | Filamin/ABP280 repeat | 11 | 48 | 4.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/20210|m.6926 | UnnamedSample_HQ_transcript/20210 | Coverage 0.337 too low. | ca40edd772f23e126cb562101e22ed00 | 507 | Pfam | PF00630 | Filamin/ABP280 repeat | 208 | 280 | 2.5E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/20210|m.6926 | UnnamedSample_HQ_transcript/20210 | Coverage 0.337 too low. | ca40edd772f23e126cb562101e22ed00 | 507 | Pfam | PF00630 | Filamin/ABP280 repeat | 289 | 374 | 2.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/39997|m.11845 | UnnamedSample_HQ_transcript/39997 | Coverage 0.981 too low. | 005d7b4cfd47c507197741817b4e823f | 307 | Pfam | PF00026 | Eukaryotic aspartyl protease | 2 | 294 | 1.3E-35 | T | 22-09-2020 | IPR033121 | Peptidase family A1 domain |
| UnnamedSample_HQ_transcript/103399|m.23034 | UnnamedSample_HQ_transcript/103399 | Coverage 0.169 too low. | 8c14ff20e0a149482d7f6ecc612a9c5a | 254 | Pfam | PF13561 | Enoyl-(Acyl carrier protein) reductase | 13 | 251 | 4.8E-70 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/104043|m.23111 | UnnamedSample_HQ_transcript/104043 | Coverage 0.985 too low. | 06169acfb47248385c073516da369ec8 | 266 | Pfam | PF10417 | C-terminal domain of 1-Cys peroxiredoxin | 228 | 263 | 5.6E-15 | T | 22-09-2020 | IPR019479 | Peroxiredoxin, C-terminal |
| UnnamedSample_HQ_transcript/104043|m.23111 | UnnamedSample_HQ_transcript/104043 | Coverage 0.985 too low. | 06169acfb47248385c073516da369ec8 | 266 | Pfam | PF00578 | AhpC/TSA family | 75 | 207 | 1.7E-36 | T | 22-09-2020 | IPR000866 | Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant |
| UnnamedSample_HQ_transcript/81987|m.20029 | UnnamedSample_HQ_transcript/81987 | Coverage 0.579 too low. | 5d07942ea6fc423d983f78e2d8df2f84 | 393 | Pfam | PF15997 | Domain of unknown function (DUF4772) | 5 | 120 | 1.1E-33 | T | 22-09-2020 | IPR031940 | Domain of unknown function DUF4772 |
| UnnamedSample_HQ_transcript/38385|m.11479 | UnnamedSample_HQ_transcript/38385 | Unmapped. | 3628882ab9730287a257f200988a36a7 | 147 | Pfam | PF03143 | Elongation factor Tu C-terminal domain | 51 | 145 | 5.3E-39 | T | 22-09-2020 | IPR004160 | Translation elongation factor EFTu/EF1A, C-terminal |
| UnnamedSample_HQ_transcript/38385|m.11479 | UnnamedSample_HQ_transcript/38385 | Unmapped. | 3628882ab9730287a257f200988a36a7 | 147 | Pfam | PF03144 | Elongation factor Tu domain 2 | 5 | 46 | 1.9E-7 | T | 22-09-2020 | IPR004161 | Translation elongation factor EFTu-like, domain 2 |
| UnnamedSample_HQ_transcript/29890|m.9454 | UnnamedSample_HQ_transcript/29890 | Coverage 0.283 too low. | d57fa667e1dc230f0de8d4a408d7c43c | 603 | Pfam | PF02210 | Laminin G domain | 58 | 177 | 9.8E-13 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/29890|m.9454 | UnnamedSample_HQ_transcript/29890 | Coverage 0.283 too low. | d57fa667e1dc230f0de8d4a408d7c43c | 603 | Pfam | PF02210 | Laminin G domain | 455 | 582 | 1.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/29890|m.9454 | UnnamedSample_HQ_transcript/29890 | Coverage 0.283 too low. | d57fa667e1dc230f0de8d4a408d7c43c | 603 | Pfam | PF02210 | Laminin G domain | 278 | 404 | 2.3E-23 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF07645 | Calcium-binding EGF domain | 419 | 451 | 6.5E-8 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF07645 | Calcium-binding EGF domain | 188 | 222 | 3.0E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF07645 | Calcium-binding EGF domain | 877 | 912 | 8.0E-7 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF07645 | Calcium-binding EGF domain | 459 | 492 | 1.6E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF07645 | Calcium-binding EGF domain | 302 | 335 | 2.2E-8 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 651 | 680 | 7.9E-9 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 957 | 987 | 1.5E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 346 | 374 | 8.4E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1156 | 1186 | 2.1E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 727 | 757 | 2.1E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 540 | 567 | 1.1E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 613 | 643 | 1.1E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 689 | 718 | 1.0E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 996 | 1025 | 2.1E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1389 | 1419 | 7.6E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1071 | 1100 | 3.1E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1124 | 1148 | 1.8E-4 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1270 | 1301 | 4.0E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 919 | 949 | 1.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 576 | 604 | 4.1E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1033 | 1063 | 1.0E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 1194 | 1222 | 3.0E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 229 | 259 | 4.5E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 500 | 530 | 8.0E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 74 | 105 | 3.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 765 | 795 | 6.8E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 383 | 413 | 2.0E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 268 | 298 | 5.6E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 803 | 833 | 1.0E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00008 | EGF-like domain | 116 | 147 | 2.1E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF07684 | NOTCH protein | 1618 | 1675 | 6.8E-16 | T | 22-09-2020 | IPR011656 | Notch, NODP domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00066 | LNR domain | 1478 | 1514 | 1.9E-11 | T | 22-09-2020 | IPR000800 | Notch domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00066 | LNR domain | 1519 | 1552 | 1.0E-9 | T | 22-09-2020 | IPR000800 | Notch domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF00066 | LNR domain | 1440 | 1472 | 1.4E-8 | T | 22-09-2020 | IPR000800 | Notch domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF06816 | NOTCH protein | 1556 | 1609 | 9.4E-18 | T | 22-09-2020 | IPR010660 | Notch, NOD domain |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF11936 | Domain of unknown function (DUF3454) | 2292 | 2332 | 3.9E-7 | T | 22-09-2020 | IPR024600 | Domain of unknown function DUF3454, notch |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF13857 | Ankyrin repeats (many copies) | 1876 | 1917 | 5.3E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF12661 | Human growth factor-like EGF | 1315 | 1336 | 0.033 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF12661 | Human growth factor-like EGF | 159 | 180 | 4.4E-4 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF12661 | Human growth factor-like EGF | 1237 | 1258 | 2.0E-6 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/271|m.227 | UnnamedSample_HQ_transcript/271 | Coverage 0.833 too low. | 9eef08095894ea7e84a88a31da1d0261 | 2347 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 1921 | 2009 | 6.5E-12 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/96328|m.22144 | UnnamedSample_HQ_transcript/96328 | Coverage 0.884 too low. | a44a23398e1aa5f7ad7897cc4ee99c57 | 259 | Pfam | PF05478 | Prominin | 45 | 253 | 1.8E-49 | T | 22-09-2020 | IPR008795 | Prominin |
| UnnamedSample_HQ_transcript/85552|m.20580 | UnnamedSample_HQ_transcript/85552 | Coverage 0.712 too low. | a44a23398e1aa5f7ad7897cc4ee99c57 | 259 | Pfam | PF05478 | Prominin | 45 | 253 | 1.8E-49 | T | 22-09-2020 | IPR008795 | Prominin |
| UnnamedSample_HQ_transcript/6991|m.2857 | UnnamedSample_HQ_transcript/6991 | Coverage 0.074 too low. | 70816e467799114420481e30eee17831 | 874 | Pfam | PF00567 | Tudor domain | 672 | 792 | 1.9E-22 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/6991|m.2857 | UnnamedSample_HQ_transcript/6991 | Coverage 0.074 too low. | 70816e467799114420481e30eee17831 | 874 | Pfam | PF00013 | KH domain | 574 | 635 | 1.4E-10 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/32032|m.9957 | UnnamedSample_HQ_transcript/32032 | Coverage 0.133 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/20377|m.6970 | UnnamedSample_HQ_transcript/20377 | Coverage 0.109 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/31593|m.9848 | UnnamedSample_HQ_transcript/31593 | Coverage 0.128 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/18738|m.6513 | UnnamedSample_HQ_transcript/18738 | Coverage 0.106 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/26046|m.8488 | UnnamedSample_HQ_transcript/26046 | Coverage 0.129 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/27131|m.8756 | UnnamedSample_HQ_transcript/27131 | Coverage 0.121 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/24400|m.8046 | UnnamedSample_HQ_transcript/24400 | Coverage 0.117 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/25709|m.8396 | UnnamedSample_HQ_transcript/25709 | Coverage 0.119 too low. | 35ce59187ecc0e299f63b680881c26c0 | 535 | Pfam | PF14719 | Phosphotyrosine interaction domain (PTB/PID) | 44 | 226 | 2.8E-84 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/26079|m.8499 | UnnamedSample_HQ_transcript/26079 | Coverage 0.085 too low. | 528bc431a43f3a2ce78d48b67688baab | 294 | Pfam | PF00026 | Eukaryotic aspartyl protease | 36 | 281 | 8.3E-35 | T | 22-09-2020 | IPR033121 | Peptidase family A1 domain |
| UnnamedSample_HQ_transcript/7106|m.2894 | UnnamedSample_HQ_transcript/7106 | Coverage 0.947 too low. | 081410cf31cf89b6e5639126f318d250 | 1230 | Pfam | PF13589 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 25 | 127 | 1.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7106|m.2894 | UnnamedSample_HQ_transcript/7106 | Coverage 0.947 too low. | 081410cf31cf89b6e5639126f318d250 | 1230 | Pfam | PF08676 | MutL C terminal dimerisation domain | 1105 | 1196 | 1.8E-7 | T | 22-09-2020 | IPR014790 | MutL, C-terminal, dimerisation |
| UnnamedSample_HQ_transcript/113782|m.24268 | UnnamedSample_HQ_transcript/113782 | Coverage 0.380 too low. | 32e0206219e2cc4eba1f96f9f87f5885 | 263 | Pfam | PF01168 | Alanine racemase, N-terminal domain | 48 | 263 | 4.4E-21 | T | 22-09-2020 | IPR001608 | Alanine racemase, N-terminal |
| UnnamedSample_HQ_transcript/6626|m.2749 | UnnamedSample_HQ_transcript/6626 | Identity 0.862 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 1165 | 1258 | 6.0E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/6626|m.2749 | UnnamedSample_HQ_transcript/6626 | Identity 0.862 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00176 | SNF2 family N-terminal domain | 528 | 796 | 3.0E-62 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/6626|m.2749 | UnnamedSample_HQ_transcript/6626 | Identity 0.862 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 411 | 474 | 3.6E-16 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/6626|m.2749 | UnnamedSample_HQ_transcript/6626 | Identity 0.862 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 294 | 366 | 4.4E-9 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/6626|m.2749 | UnnamedSample_HQ_transcript/6626 | Identity 0.862 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00271 | Helicase conserved C-terminal domain | 823 | 935 | 1.1E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/4534|m.2010 | UnnamedSample_HQ_transcript/4534 | Identity 0.867 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 1165 | 1258 | 6.0E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/4534|m.2010 | UnnamedSample_HQ_transcript/4534 | Identity 0.867 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00176 | SNF2 family N-terminal domain | 528 | 796 | 3.0E-62 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/4534|m.2010 | UnnamedSample_HQ_transcript/4534 | Identity 0.867 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 411 | 474 | 3.6E-16 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/4534|m.2010 | UnnamedSample_HQ_transcript/4534 | Identity 0.867 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 294 | 366 | 4.4E-9 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/4534|m.2010 | UnnamedSample_HQ_transcript/4534 | Identity 0.867 too low. | 2aad20ff723bb24995c192913ed9aa47 | 1430 | Pfam | PF00271 | Helicase conserved C-terminal domain | 823 | 935 | 1.1E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/42325|m.12332 | UnnamedSample_HQ_transcript/42325 | Coverage 0.202 too low. | 5958e48a6ce611d9e742c23873dae425 | 521 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 257 | 504 | 1.1E-58 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/8550|m.3363 | UnnamedSample_HQ_transcript/8550 | Coverage 0.404 too low. | 5958e48a6ce611d9e742c23873dae425 | 521 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 257 | 504 | 1.1E-58 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/6613|m.2742 | UnnamedSample_HQ_transcript/6613 | Coverage 0.332 too low. | f7f6f0d5844c1d0f4b67d589dfd46af6 | 998 | Pfam | PF02985 | HEAT repeat | 315 | 338 | 4.2E-4 | T | 22-09-2020 | IPR000357 | HEAT repeat |
| UnnamedSample_HQ_transcript/6613|m.2742 | UnnamedSample_HQ_transcript/6613 | Coverage 0.332 too low. | f7f6f0d5844c1d0f4b67d589dfd46af6 | 998 | Pfam | PF00400 | WD domain, G-beta repeat | 723 | 750 | 0.15 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/6613|m.2742 | UnnamedSample_HQ_transcript/6613 | Coverage 0.332 too low. | f7f6f0d5844c1d0f4b67d589dfd46af6 | 998 | Pfam | PF00400 | WD domain, G-beta repeat | 824 | 852 | 0.22 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/49796|m.13981 | UnnamedSample_HQ_transcript/49796 | Coverage 0.103 too low. | d80062b808d2c64f3491bcd02f309cdb | 392 | Pfam | PF13873 | Myb/SANT-like DNA-binding domain | 10 | 87 | 3.2E-16 | T | 22-09-2020 | IPR028002 | Myb/SANT-like DNA-binding domain |
| UnnamedSample_HQ_transcript/99690|m.22589 | UnnamedSample_HQ_transcript/99690 | Coverage 0.920 too low. | 0008322ead05c5586aa7d1d2fa2e7cea | 260 | Pfam | PF06585 | Haemolymph juvenile hormone binding protein (JHBP) | 20 | 256 | 1.4E-63 | T | 22-09-2020 | IPR010562 | Haemolymph juvenile hormone binding |
| UnnamedSample_HQ_transcript/94558|m.21887 | UnnamedSample_HQ_transcript/94558 | Coverage 0.845 too low. | 0008322ead05c5586aa7d1d2fa2e7cea | 260 | Pfam | PF06585 | Haemolymph juvenile hormone binding protein (JHBP) | 20 | 256 | 1.4E-63 | T | 22-09-2020 | IPR010562 | Haemolymph juvenile hormone binding |
| UnnamedSample_HQ_transcript/16930|m.5982 | UnnamedSample_HQ_transcript/16930 | Coverage 0.212 too low. | 030d0f526d65c257812e283a4e327cf0 | 674 | Pfam | PF00431 | CUB domain | 236 | 321 | 5.3E-9 | T | 22-09-2020 | IPR000859 | CUB domain |
| UnnamedSample_HQ_transcript/16930|m.5982 | UnnamedSample_HQ_transcript/16930 | Coverage 0.212 too low. | 030d0f526d65c257812e283a4e327cf0 | 674 | Pfam | PF00431 | CUB domain | 79 | 184 | 2.4E-24 | T | 22-09-2020 | IPR000859 | CUB domain |
| UnnamedSample_HQ_transcript/16930|m.5982 | UnnamedSample_HQ_transcript/16930 | Coverage 0.212 too low. | 030d0f526d65c257812e283a4e327cf0 | 674 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 329 | 366 | 2.9E-7 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/20383|m.6972 | UnnamedSample_HQ_transcript/20383 | Coverage 0.965 too low. | 52cee1bfc4346ab1b432cb6002f8d1d4 | 249 | Pfam | PF00069 | Protein kinase domain | 10 | 146 | 5.2E-16 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/8040|m.3199 | UnnamedSample_HQ_transcript/8040 | Unmapped. | 275c3a4668568c1362a9693874dfa0d0 | 1218 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 852 | 1177 | 1.2E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/8081|m.3217 | UnnamedSample_HQ_transcript/8081 | Unmapped. | 275c3a4668568c1362a9693874dfa0d0 | 1218 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 852 | 1177 | 1.2E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/8869|m.3470 | UnnamedSample_HQ_transcript/8869 | Unmapped. | 275c3a4668568c1362a9693874dfa0d0 | 1218 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 852 | 1177 | 1.2E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/5955|m.2525 | UnnamedSample_HQ_transcript/5955 | Coverage 0.116 too low. | 275c3a4668568c1362a9693874dfa0d0 | 1218 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 852 | 1177 | 1.2E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/8013|m.3188 | UnnamedSample_HQ_transcript/8013 | Unmapped. | 275c3a4668568c1362a9693874dfa0d0 | 1218 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 852 | 1177 | 1.2E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/70136|m.17947 | UnnamedSample_HQ_transcript/70136 | Coverage 0.401 too low. | bbdeecf510c92a662faeefe44011f356 | 362 | Pfam | PF00096 | Zinc finger, C2H2 type | 335 | 358 | 4.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/33199|m.10256 | UnnamedSample_HQ_transcript/33199 | Coverage 0.738 too low. | 47994464c5ee6e20642bca973857c900 | 526 | Pfam | PF02145 | Rap/ran-GAP | 93 | 273 | 3.1E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/18024|m.6308 | UnnamedSample_HQ_transcript/18024 | Coverage 0.476 too low. | 15167ccd522dfe0151ca0aa381f62ec4 | 604 | Pfam | PF00501 | AMP-binding enzyme | 27 | 496 | 2.0E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/188|m.170 | UnnamedSample_HQ_transcript/188 | Coverage 0.987 too low. | b561994868820381385a7991df5d3f64 | 2740 | Pfam | PF13820 | Putative nucleic acid-binding region | 15 | 175 | 4.5E-29 | T | 22-09-2020 | IPR032715 | Nuclear receptor coactivator 6, putative nucleic acid-binding region |
| UnnamedSample_HQ_transcript/110066|m.23843 | UnnamedSample_HQ_transcript/110066 | Coverage 0.164 too low. | c0994cd96515baf1924cc6eff15fd811 | 126 | Pfam | PF00046 | Homeodomain | 2 | 27 | 8.2E-10 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/81814|m.20004 | UnnamedSample_HQ_transcript/81814 | Identity 0.699 too low. | 90a2f9deaca4155f436894d02de2c692 | 308 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 1 | 39 | 2.4E-4 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/81814|m.20004 | UnnamedSample_HQ_transcript/81814 | Identity 0.699 too low. | 90a2f9deaca4155f436894d02de2c692 | 308 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 62 | 119 | 1.2E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/58029|m.15658 | UnnamedSample_HQ_transcript/58029 | Coverage 0.980 too low. | 90a2f9deaca4155f436894d02de2c692 | 308 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 1 | 39 | 2.4E-4 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/58029|m.15658 | UnnamedSample_HQ_transcript/58029 | Coverage 0.980 too low. | 90a2f9deaca4155f436894d02de2c692 | 308 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 62 | 119 | 1.2E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/65405|m.17103 | UnnamedSample_HQ_transcript/65405 | Coverage 0.658 too low. | 90a2f9deaca4155f436894d02de2c692 | 308 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 1 | 39 | 2.4E-4 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/65405|m.17103 | UnnamedSample_HQ_transcript/65405 | Coverage 0.658 too low. | 90a2f9deaca4155f436894d02de2c692 | 308 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 62 | 119 | 1.2E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/19573|m.6748 | UnnamedSample_HQ_transcript/19573 | Identity 0.948 too low. | c89778dec62b4b92d093557fccb85f46 | 727 | Pfam | PF00520 | Ion transport protein | 307 | 554 | 3.0E-12 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/19573|m.6748 | UnnamedSample_HQ_transcript/19573 | Identity 0.948 too low. | c89778dec62b4b92d093557fccb85f46 | 727 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 49 | 138 | 1.0E-7 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/19573|m.6748 | UnnamedSample_HQ_transcript/19573 | Identity 0.948 too low. | c89778dec62b4b92d093557fccb85f46 | 727 | Pfam | PF00023 | Ankyrin repeat | 166 | 196 | 0.02 | T | 22-09-2020 | IPR002110 | Ankyrin repeat |
| UnnamedSample_HQ_transcript/32991|m.10210 | UnnamedSample_HQ_transcript/32991 | Identity 0.937 too low. | c89778dec62b4b92d093557fccb85f46 | 727 | Pfam | PF00520 | Ion transport protein | 307 | 554 | 3.0E-12 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/32991|m.10210 | UnnamedSample_HQ_transcript/32991 | Identity 0.937 too low. | c89778dec62b4b92d093557fccb85f46 | 727 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 49 | 138 | 1.0E-7 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/32991|m.10210 | UnnamedSample_HQ_transcript/32991 | Identity 0.937 too low. | c89778dec62b4b92d093557fccb85f46 | 727 | Pfam | PF00023 | Ankyrin repeat | 166 | 196 | 0.02 | T | 22-09-2020 | IPR002110 | Ankyrin repeat |
| UnnamedSample_HQ_transcript/34059|m.10479 | UnnamedSample_HQ_transcript/34059 | Coverage 0.964 too low. | 4d0665410df878a3d34e74c162d09ecc | 475 | Pfam | PF00651 | BTB/POZ domain | 22 | 127 | 2.2E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/34059|m.10479 | UnnamedSample_HQ_transcript/34059 | Coverage 0.964 too low. | 4d0665410df878a3d34e74c162d09ecc | 475 | Pfam | PF13894 | C2H2-type zinc finger | 434 | 456 | 7.7E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/29100|m.9255 | UnnamedSample_HQ_transcript/29100 | Coverage 0.963 too low. | 4d0665410df878a3d34e74c162d09ecc | 475 | Pfam | PF00651 | BTB/POZ domain | 22 | 127 | 2.2E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/29100|m.9255 | UnnamedSample_HQ_transcript/29100 | Coverage 0.963 too low. | 4d0665410df878a3d34e74c162d09ecc | 475 | Pfam | PF13894 | C2H2-type zinc finger | 434 | 456 | 7.7E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/108552|m.23651 | UnnamedSample_HQ_transcript/108552 | Coverage 0.514 too low. | ffd1cdf35c209b67af6e1bec7b096349 | 214 | Pfam | PF00246 | Zinc carboxypeptidase | 4 | 174 | 7.8E-29 | T | 22-09-2020 | IPR000834 | Peptidase M14, carboxypeptidase A |
| UnnamedSample_HQ_transcript/20156|m.6911 | UnnamedSample_HQ_transcript/20156 | Coverage 0.740 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 380 | 583 | 1.9E-32 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/20156|m.6911 | UnnamedSample_HQ_transcript/20156 | Coverage 0.740 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 27 | 377 | 7.0E-108 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/24773|m.8160 | UnnamedSample_HQ_transcript/24773 | Coverage 0.783 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 380 | 583 | 1.9E-32 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/24773|m.8160 | UnnamedSample_HQ_transcript/24773 | Coverage 0.783 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 27 | 377 | 7.0E-108 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/30374|m.9558 | UnnamedSample_HQ_transcript/30374 | Coverage 0.845 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 380 | 583 | 1.9E-32 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/30374|m.9558 | UnnamedSample_HQ_transcript/30374 | Coverage 0.845 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 27 | 377 | 7.0E-108 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/29963|m.9473 | UnnamedSample_HQ_transcript/29963 | Coverage 0.776 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 380 | 583 | 1.9E-32 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/29963|m.9473 | UnnamedSample_HQ_transcript/29963 | Coverage 0.776 too low. | aa3c91d1bab6c74c5c09a38a4d2c4a2b | 673 | Pfam | PF01153 | Glypican | 27 | 377 | 7.0E-108 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/75021|m.18847 | UnnamedSample_HQ_transcript/75021 | Coverage 0.841 too low. | e4f54d719724fb9c3c0f0241546addbe | 507 | Pfam | PF00271 | Helicase conserved C-terminal domain | 241 | 373 | 6.4E-29 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/75021|m.18847 | UnnamedSample_HQ_transcript/75021 | Coverage 0.841 too low. | e4f54d719724fb9c3c0f0241546addbe | 507 | Pfam | PF00270 | DEAD/DEAH box helicase | 31 | 202 | 1.9E-38 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/40606|m.11981 | UnnamedSample_HQ_transcript/40606 | Coverage 0.951 too low. | 2f93a8629e01ae30c8603b942083a6f5 | 390 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 53 | 388 | 1.7E-84 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/99316|m.22544 | UnnamedSample_HQ_transcript/99316 | Identity 0.944 too low. | 509ba2fb4ca6a4373352eea34251c373 | 176 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 1 | 139 | 5.1E-23 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00052 | Laminin B (Domain IV) | 10 | 145 | 5.7E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF02210 | Laminin G domain | 1072 | 1225 | 2.0E-11 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF06009 | Laminin Domain II | 936 | 1058 | 1.6E-9 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 435 | 474 | 3.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 146 | 170 | 1.4E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 230 | 285 | 1.2E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 180 | 227 | 4.2E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 341 | 385 | 2.2E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 288 | 338 | 2.5E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1094|m.676 | UnnamedSample_HQ_transcript/1094 | Coverage 0.130 too low. | d0702eaced9d604400875b1efe6f5679 | 1248 | Pfam | PF00053 | Laminin EGF domain | 388 | 432 | 2.6E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/46432|m.13240 | UnnamedSample_HQ_transcript/46432 | Coverage 0.791 too low. | ee54429e8b31549e29fef29e4086a468 | 718 | Pfam | PF13927 | Immunoglobulin domain | 620 | 702 | 4.0E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/42168|m.12302 | UnnamedSample_HQ_transcript/42168 | Coverage 0.761 too low. | ee54429e8b31549e29fef29e4086a468 | 718 | Pfam | PF13927 | Immunoglobulin domain | 620 | 702 | 4.0E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/42381|m.12345 | UnnamedSample_HQ_transcript/42381 | Coverage 0.968 too low. | 461385b3ff42c10c5a079e4dde153e80 | 205 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 5 | 202 | 1.0E-67 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/36159|m.10972 | UnnamedSample_HQ_transcript/36159 | Coverage 0.053 too low. | 9b7a7e01118fbb8018f03a8067f735cc | 448 | Pfam | PF13896 | Glycosyl-transferase for dystroglycan | 233 | 438 | 1.1E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/36159|m.10972 | UnnamedSample_HQ_transcript/36159 | Coverage 0.053 too low. | 9b7a7e01118fbb8018f03a8067f735cc | 448 | Pfam | PF13896 | Glycosyl-transferase for dystroglycan | 169 | 232 | 7.7E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/41245|m.12107 | UnnamedSample_HQ_transcript/41245 | Coverage 0.982 too low. | 9b7a7e01118fbb8018f03a8067f735cc | 448 | Pfam | PF13896 | Glycosyl-transferase for dystroglycan | 233 | 438 | 1.1E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/41245|m.12107 | UnnamedSample_HQ_transcript/41245 | Coverage 0.982 too low. | 9b7a7e01118fbb8018f03a8067f735cc | 448 | Pfam | PF13896 | Glycosyl-transferase for dystroglycan | 169 | 232 | 7.7E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32319|m.10036 | UnnamedSample_HQ_transcript/32319 | Identity 0.634 too low. | c8580428ef0164146a8830e8f00d0039 | 455 | Pfam | PF13927 | Immunoglobulin domain | 172 | 227 | 1.1E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32319|m.10036 | UnnamedSample_HQ_transcript/32319 | Identity 0.634 too low. | c8580428ef0164146a8830e8f00d0039 | 455 | Pfam | PF13927 | Immunoglobulin domain | 44 | 127 | 1.7E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32319|m.10036 | UnnamedSample_HQ_transcript/32319 | Identity 0.634 too low. | c8580428ef0164146a8830e8f00d0039 | 455 | Pfam | PF07679 | Immunoglobulin I-set domain | 271 | 325 | 1.5E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/26166|m.8520 | UnnamedSample_HQ_transcript/26166 | Identity 0.659 too low. | c8580428ef0164146a8830e8f00d0039 | 455 | Pfam | PF13927 | Immunoglobulin domain | 172 | 227 | 1.1E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/26166|m.8520 | UnnamedSample_HQ_transcript/26166 | Identity 0.659 too low. | c8580428ef0164146a8830e8f00d0039 | 455 | Pfam | PF13927 | Immunoglobulin domain | 44 | 127 | 1.7E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/26166|m.8520 | UnnamedSample_HQ_transcript/26166 | Identity 0.659 too low. | c8580428ef0164146a8830e8f00d0039 | 455 | Pfam | PF07679 | Immunoglobulin I-set domain | 271 | 325 | 1.5E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/72373|m.18362 | UnnamedSample_HQ_transcript/72373 | Coverage 0.085 too low. | 1d0bb900b820be73f43cb1da47c2822a | 327 | Pfam | PF00112 | Papain family cysteine protease | 122 | 325 | 6.8E-44 | T | 22-09-2020 | IPR000668 | Peptidase C1A, papain C-terminal |
| UnnamedSample_HQ_transcript/72373|m.18362 | UnnamedSample_HQ_transcript/72373 | Coverage 0.085 too low. | 1d0bb900b820be73f43cb1da47c2822a | 327 | Pfam | PF08246 | Cathepsin propeptide inhibitor domain (I29) | 6 | 60 | 9.2E-11 | T | 22-09-2020 | IPR013201 | Cathepsin propeptide inhibitor domain (I29) |
| UnnamedSample_HQ_transcript/63739|m.16784 | UnnamedSample_HQ_transcript/63739 | Coverage 0.390 too low. | 5ba4b7da9f04c5f3374ee8ac2d8f65e7 | 388 | Pfam | PF00412 | LIM domain | 54 | 102 | 6.6E-11 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/63739|m.16784 | UnnamedSample_HQ_transcript/63739 | Coverage 0.390 too low. | 5ba4b7da9f04c5f3374ee8ac2d8f65e7 | 388 | Pfam | PF00412 | LIM domain | 275 | 328 | 5.3E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/63739|m.16784 | UnnamedSample_HQ_transcript/63739 | Coverage 0.390 too low. | 5ba4b7da9f04c5f3374ee8ac2d8f65e7 | 388 | Pfam | PF00412 | LIM domain | 334 | 386 | 1.8E-11 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/110455|m.23889 | UnnamedSample_HQ_transcript/110455 | Identity 0.948 too low. | d0ca0f4931fd6e71e1fca95f72a24198 | 229 | Pfam | PF00036 | EF hand | 81 | 106 | 1.4E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/110455|m.23889 | UnnamedSample_HQ_transcript/110455 | Identity 0.948 too low. | d0ca0f4931fd6e71e1fca95f72a24198 | 229 | Pfam | PF13499 | EF-hand domain pair | 147 | 209 | 3.2E-13 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/72605|m.18403 | UnnamedSample_HQ_transcript/72605 | Identity 0.614 too low. | 272b7f4d707fda3e85a164d758a239fd | 554 | Pfam | PF00168 | C2 domain | 292 | 398 | 1.7E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/72605|m.18403 | UnnamedSample_HQ_transcript/72605 | Identity 0.614 too low. | 272b7f4d707fda3e85a164d758a239fd | 554 | Pfam | PF00168 | C2 domain | 442 | 533 | 1.2E-8 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/72605|m.18403 | UnnamedSample_HQ_transcript/72605 | Identity 0.614 too low. | 272b7f4d707fda3e85a164d758a239fd | 554 | Pfam | PF17047 | Synaptotagmin-like mitochondrial-lipid-binding domain | 98 | 275 | 3.4E-40 | T | 22-09-2020 | IPR039010 | Synaptotagmin, SMP domain |
| UnnamedSample_HQ_transcript/85779|m.20615 | UnnamedSample_HQ_transcript/85779 | Unmapped. | 792492e4a91734a429739fb4fb79be88 | 358 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 43 | 289 | 4.3E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/90478|m.21325 | UnnamedSample_HQ_transcript/90478 | Coverage 0.989 too low. | c2c68a98270b0a6a5d712d572c201025 | 356 | Pfam | PF00224 | Pyruvate kinase, barrel domain | 2 | 214 | 2.5E-105 | T | 22-09-2020 | IPR015793 | Pyruvate kinase, barrel |
| UnnamedSample_HQ_transcript/90478|m.21325 | UnnamedSample_HQ_transcript/90478 | Coverage 0.989 too low. | c2c68a98270b0a6a5d712d572c201025 | 356 | Pfam | PF02887 | Pyruvate kinase, alpha/beta domain | 230 | 348 | 7.9E-34 | T | 22-09-2020 | IPR015795 | Pyruvate kinase, C-terminal |
| UnnamedSample_HQ_transcript/82138|m.20054 | UnnamedSample_HQ_transcript/82138 | Coverage 0.693 too low. | 1197eb4e5684a66b9eb94ff0758595ea | 424 | Pfam | PF06155 | Gamma-butyrobetaine hydroxylase-like, N-terminal | 54 | 127 | 2.7E-10 | T | 22-09-2020 | IPR010376 | Gamma-butyrobetaine hydroxylase-like, N-terminal |
| UnnamedSample_HQ_transcript/82138|m.20054 | UnnamedSample_HQ_transcript/82138 | Coverage 0.693 too low. | 1197eb4e5684a66b9eb94ff0758595ea | 424 | Pfam | PF02668 | Taurine catabolism dioxygenase TauD, TfdA family | 158 | 402 | 2.9E-31 | T | 22-09-2020 | IPR003819 | TauD/TfdA-like domain |
| UnnamedSample_HQ_transcript/75775|m.18981 | UnnamedSample_HQ_transcript/75775 | Coverage 0.714 too low. | 1197eb4e5684a66b9eb94ff0758595ea | 424 | Pfam | PF06155 | Gamma-butyrobetaine hydroxylase-like, N-terminal | 54 | 127 | 2.7E-10 | T | 22-09-2020 | IPR010376 | Gamma-butyrobetaine hydroxylase-like, N-terminal |
| UnnamedSample_HQ_transcript/75775|m.18981 | UnnamedSample_HQ_transcript/75775 | Coverage 0.714 too low. | 1197eb4e5684a66b9eb94ff0758595ea | 424 | Pfam | PF02668 | Taurine catabolism dioxygenase TauD, TfdA family | 158 | 402 | 2.9E-31 | T | 22-09-2020 | IPR003819 | TauD/TfdA-like domain |
| UnnamedSample_HQ_transcript/84973|m.20497 | UnnamedSample_HQ_transcript/84973 | Coverage 0.725 too low. | 1197eb4e5684a66b9eb94ff0758595ea | 424 | Pfam | PF06155 | Gamma-butyrobetaine hydroxylase-like, N-terminal | 54 | 127 | 2.7E-10 | T | 22-09-2020 | IPR010376 | Gamma-butyrobetaine hydroxylase-like, N-terminal |
| UnnamedSample_HQ_transcript/84973|m.20497 | UnnamedSample_HQ_transcript/84973 | Coverage 0.725 too low. | 1197eb4e5684a66b9eb94ff0758595ea | 424 | Pfam | PF02668 | Taurine catabolism dioxygenase TauD, TfdA family | 158 | 402 | 2.9E-31 | T | 22-09-2020 | IPR003819 | TauD/TfdA-like domain |
| UnnamedSample_HQ_transcript/12257|m.4575 | UnnamedSample_HQ_transcript/12257 | Coverage 0.869 too low. | aa2ddb377e56ab97c86e0cc9ea0bee61 | 1192 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 766 | 1.4E-284 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/12257|m.4575 | UnnamedSample_HQ_transcript/12257 | Coverage 0.869 too low. | aa2ddb377e56ab97c86e0cc9ea0bee61 | 1192 | Pfam | PF01576 | Myosin tail | 846 | 1192 | 5.2E-50 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/12257|m.4575 | UnnamedSample_HQ_transcript/12257 | Coverage 0.869 too low. | aa2ddb377e56ab97c86e0cc9ea0bee61 | 1192 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 2.9E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/118959|m.24772 | UnnamedSample_HQ_transcript/118959 | Coverage 0.990 too low. | ef3d786d5454bba8bb56e661545339fc | 190 | Pfam | PF00312 | Ribosomal protein S15 | 6 | 84 | 9.5E-16 | T | 22-09-2020 | IPR000589 | Ribosomal protein S15 |
| UnnamedSample_HQ_transcript/3714|m.1695 | UnnamedSample_HQ_transcript/3714 | Coverage 0.115 too low. | 5ca51dc647d345dd750c81b83f6800d6 | 1415 | Pfam | PF09469 | Cordon-bleu ubiquitin-like domain | 105 | 189 | 1.1E-5 | T | 22-09-2020 | IPR019025 | Cordon-bleu, ubiquitin-like domain |
| UnnamedSample_HQ_transcript/3251|m.1542 | UnnamedSample_HQ_transcript/3251 | Coverage 0.112 too low. | 5ca51dc647d345dd750c81b83f6800d6 | 1415 | Pfam | PF09469 | Cordon-bleu ubiquitin-like domain | 105 | 189 | 1.1E-5 | T | 22-09-2020 | IPR019025 | Cordon-bleu, ubiquitin-like domain |
| UnnamedSample_HQ_transcript/18588|m.6467 | UnnamedSample_HQ_transcript/18588 | Coverage 0.669 too low. | 6a53de86538f9a14834d659f6c231933 | 980 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 548 | 684 | 9.7E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/18588|m.6467 | UnnamedSample_HQ_transcript/18588 | Coverage 0.669 too low. | 6a53de86538f9a14834d659f6c231933 | 980 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 130 | 397 | 3.8E-36 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/18588|m.6467 | UnnamedSample_HQ_transcript/18588 | Coverage 0.669 too low. | 6a53de86538f9a14834d659f6c231933 | 980 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 766 | 973 | 1.1E-72 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/54468|m.14933 | UnnamedSample_HQ_transcript/54468 | Identity 0.905 too low. | 2370eab308d52f64e8ee7f8d5b7844c1 | 474 | Pfam | PF04515 | Plasma-membrane choline transporter | 162 | 439 | 2.5E-73 | T | 22-09-2020 | IPR007603 | Choline transporter-like |
| UnnamedSample_HQ_transcript/27900|m.8939 | UnnamedSample_HQ_transcript/27900 | Coverage 0.933 too low. | 61779f86eec15d486d74328a2b4613b2 | 775 | Pfam | PF01436 | NHL repeat | 748 | 775 | 4.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/27900|m.8939 | UnnamedSample_HQ_transcript/27900 | Coverage 0.933 too low. | 61779f86eec15d486d74328a2b4613b2 | 775 | Pfam | PF01436 | NHL repeat | 512 | 539 | 1.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/27900|m.8939 | UnnamedSample_HQ_transcript/27900 | Coverage 0.933 too low. | 61779f86eec15d486d74328a2b4613b2 | 775 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 559 | 738 | 1.7E-11 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/24907|m.8197 | UnnamedSample_HQ_transcript/24907 | Coverage 0.922 too low. | 61779f86eec15d486d74328a2b4613b2 | 775 | Pfam | PF01436 | NHL repeat | 748 | 775 | 4.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/24907|m.8197 | UnnamedSample_HQ_transcript/24907 | Coverage 0.922 too low. | 61779f86eec15d486d74328a2b4613b2 | 775 | Pfam | PF01436 | NHL repeat | 512 | 539 | 1.4E-9 | T | 22-09-2020 | IPR001258 | NHL repeat |
| UnnamedSample_HQ_transcript/24907|m.8197 | UnnamedSample_HQ_transcript/24907 | Coverage 0.922 too low. | 61779f86eec15d486d74328a2b4613b2 | 775 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 559 | 738 | 1.7E-11 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/28108|m.8999 | UnnamedSample_HQ_transcript/28108 | Coverage 0.954 too low. | 0e01249029fc2652927cd58271628a3d | 724 | Pfam | PF00069 | Protein kinase domain | 20 | 295 | 7.0E-63 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/28108|m.8999 | UnnamedSample_HQ_transcript/28108 | Coverage 0.954 too low. | 0e01249029fc2652927cd58271628a3d | 724 | Pfam | PF12063 | Domain of unknown function (DUF3543) | 563 | 702 | 1.7E-14 | T | 22-09-2020 | IPR022708 | Serine/threonine-protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/18186|m.6366 | UnnamedSample_HQ_transcript/18186 | Coverage 0.807 too low. | 75fb4c5d8dd0f9e7baa22b3810b4c3b8 | 320 | Pfam | PF00571 | CBS domain | 136 | 182 | 2.5E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/18186|m.6366 | UnnamedSample_HQ_transcript/18186 | Coverage 0.807 too low. | 75fb4c5d8dd0f9e7baa22b3810b4c3b8 | 320 | Pfam | PF00571 | CBS domain | 209 | 256 | 4.3E-10 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/18186|m.6366 | UnnamedSample_HQ_transcript/18186 | Coverage 0.807 too low. | 75fb4c5d8dd0f9e7baa22b3810b4c3b8 | 320 | Pfam | PF00571 | CBS domain | 63 | 109 | 5.0E-6 | T | 22-09-2020 | IPR000644 | CBS domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
